Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209777

Expand all

ROXYBOND (OXYCODONE HYDROCHLORIDE)
5MG
Marketing Status: Discontinued
Active Ingredient: OXYCODONE HYDROCHLORIDE
Proprietary Name: ROXYBOND
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N209777
Product Number: 001
Approval Date: Apr 20, 2017
Applicant Holder Full Name: OHEMO LIFE SCIENCES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
ROXYBOND (OXYCODONE HYDROCHLORIDE)
15MG
Marketing Status: Discontinued
Active Ingredient: OXYCODONE HYDROCHLORIDE
Proprietary Name: ROXYBOND
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N209777
Product Number: 002
Approval Date: Apr 20, 2017
Applicant Holder Full Name: OHEMO LIFE SCIENCES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
ROXYBOND (OXYCODONE HYDROCHLORIDE)
30MG
Marketing Status: Discontinued
Active Ingredient: OXYCODONE HYDROCHLORIDE
Proprietary Name: ROXYBOND
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N209777
Product Number: 003
Approval Date: Apr 20, 2017
Applicant Holder Full Name: OHEMO LIFE SCIENCES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English